-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/kAg43FLUnTjCU5ZNaaHQtW
March 01, 2016 - those found in primary care settings to
study the effects of comorbid conditions on screening
accuracy, type … collaborative care
group had an initial in-person session that included
their parents, choice of treatment type
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/perinatal-depression-preventive-interventions
February 12, 2019 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Perinatal Depression: Preventive Interventions
February 12, 2019
Recommendations made by the USPSTF are independent of the U.S. government. …
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/from-topic-nomination-to-clinical-practice-resources-overview.pdf
June 01, 2021 - • For Topic X, the Task Force adds additional language on the type of evidence
it will include and
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan35/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
November 15, 2013 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Research Plan
Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening
November 15, 2013
Recommendations made by the USPSTF are indepe…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
May 18, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Colorectal Cancer: Screening
May 18, 2021
Recommendations made by the USPSTF are independent of the U.S. government. They should not be…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening-2008
May 15, 2008 - outcomes for mothers or their infants. 10
With the increasing prevalence of U.S. women at high risk for type … age younger than 25 years; (2) no membership in an ethnic group with increased risk for developing type
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/L5UwXoftg4JHw4buVDhjUT
October 01, 2010 - )
Wrong population: 49
Wrong intervention: 18
Wrong outcome: 11
Wrong study design or publication
type
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/gRNjNsmqZvBC-DnHGRMgG3
December 01, 2014 - greater and specificity of
97% or greater for diagnosing gonorrhea and chlamydia, regardless
of specimen type … Amplification Tests for Gonorrhea and Chlamydia Screening
Screening Test Sensitivity/Specificity, by Specimen Type
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary24/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
March 11, 2014 - Scientific inbreeding and same-team replication: type D personality as an example. … for multisite sampling; substance use in past 12 mo at baseline; age; sex; parent education level; type
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary3/chlamydia-and-gonorrhea-screening-september-2014
September 23, 2014 - greater and specificity of 97% or greater for diagnosing gonorrhea and chlamydia, regardless of specimen type … Screening Test
Sensitivity/Specificity by Specimen Type
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/DMDPeSf_nEUM-HrVrX6c7U
June 20, 2017 - adulthood and lead to adverse cardiovascular outcomes or other obesity-related morbidity,
such as type … adulthood and lead to adverse cardiovascular outcomes or other
obesity-related morbidity, such as type … No
trials reported on other health outcomes, such as morbidity asso
ciated with type 2 diabetes or
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/XGHwLrLfb_78ymEUwGF6jR
March 19, 2024 - Ineligible or no intervention
5 Poor quality
4 Ineligible or no comparison
3 Ineligible publication type … The timing and type of outcome measurement varied
substantially across trials, and several trials presented … Supplement).13,18-21,31,39-43,49 The evidence included substan-
tial heterogeneity in the timing and type … Long-term
outcomes:
Inconsistent
Imprecise
No evidence of
reporting bias
Heterogeneity
across studies
in type
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/J-vUTejXWsdp_d86zK4Gth
July 01, 2005 - Medical conditions new to this age group, such
as type 2 diabetes mellitus, represent "adult" morbidities … However, the recent emergence of medical conditions “new” to
overweight children, such as type 2 diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening-2005
July 11, 2005 - Medical conditions new to this age group, such as type 2 diabetes mellitus, represent "adult" morbidities … However, the recent emergence of medical conditions "new" to overweight children, such as type 2 diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2002
September 17, 2002 - The likelihood of being diagnosed with osteoporosis varies greatly depending on the site and type of … The likelihood of being diagnosed with osteoporosis varies greatly depending on the site and type of
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
August 23, 2022 - Two-year statin therapy does not alter the progression of intima-media thickness in patients with type … Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative … The statins in prevention of coronary heart diseases in type 2 diabetics. … Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … : 11 Mean BP: 129/71 mm Hg Mean BMI: 28 a
Beishuizen et al, 2004 12 (Fair)
Age 30 to 80 y
Type
-
www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/bladder-cancer-screening-2004
June 07, 2004 - found no high-quality trials that compared health outcomes in treated and untreated groups with the type
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary28/cognitive-impairment-in-older-adults-screening-2014
October 22, 2013 - The validation of a mailed health survey for screening of dementia of the Alzheimer's type. … Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type. … Consistent finding of no benefit regardless of type of NSAID. … Consistent finding of no benefit regardless of type of hormone. … Consistent finding of no benefit regardless of type of dietary supplement.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZcLsqV-5K7hyfot-qHQp9
November 01, 2004 - found no high-quality trials that compared
health outcomes in treated and untreated groups
with the type
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/caCcWa2a6jQGRyb7H8CkbU
July 01, 2009 - Treatment
Most older adults will need some type of corrective
lenses.